Results 51 to 60 of about 54,777 (206)

Obstacles to Implementing the HPV Vaccine: Is it Worth Pursuing or Not?

Asian Pacific Journal of Cancer Care, 2019
Cervical cancer, along with breast, colorectal, and lung cancer, has become increasingly problematic in Malaysia. The prevalence of cervical cancer in Malaysia is projected to rise in younger women, and Malaysia views this prediction with concern and ...
Mastura Mohd Sopian, Sharifah Azdiana Tuan Din, Hasmah Hussin   +2 more
doaj   +1 more source

Human Papillomavirus Infection: Prevention, Barriers to Vaccination, and the Need for Education [PDF]

, 2016
While there is no known cure for HPV, prophylactic vaccination provides an effective method of primary prevention against HPV-related diseases. However, many females and males never receive the HPV vaccine as recommended.
Kessler, Theresa A
core   +2 more sources

Public health approach to prevent cervical cancer in HIV-infected women in Kenya : issues to consider in the design of prevention programs [PDF]

, 2017
Women living with HIV in Africa are at increased risk to be co-infected with Human Papilloma Virus (HPV), persistent high risk (HR) HPV infection and bacterial vaginosis (BV), which compounds HPV persistence, thereby increasing the risk for cervical ...
Callens, Steven, Harmon, Stacy G, Mabeya, Hillary, Menon, Sonia, Rossi, Rodolfo   +4 more
core   +3 more sources

Cervical cancer prevention by vaccination: review

Frontiers in Oncology
Routine use of human papillomavirus (HPV) vaccines is recommended in adolescents under 15 years of age worldwide. Still, effective programs remain suboptimal for several factors, making the WHO strategy to eradicate cervical cancer public health with an ...
Julio Cesar González-Rodríguez, Aurelio Cruz-Valdez, Vicente Madrid-Marina   +2 more
doaj   +1 more source

"It's a can of worms": understanding primary care practitioners' behaviours in relation to HPV using the Theoretical Domains Framework [PDF]

, 2012
Background: The relationship between infection with high-risk human papillomavirus (HPV) and cervical cancer is transforming cervical cancer prevention. HPV tests and vaccinations have recently become available.
A Songthap, A Vijayaraghavan, B Duval, C Abraham, C Pope, Cara M Martin, D Bonetti, DL Dell, DM Harper, DM Harper, FX Bosch, FX Bosch, G Agarwal, G Koliopoulos, G McCarthy, G Ronco, G Sroczynski, H Defty, I Ajzen, J Cuzick, J Murphy, J Murphy, J Murphy, J Ritchie, J Waller, JA Kahn, Jill J Francis, JJ Francis, JJ Francis, JM Riedesel, John J O’Leary, Judith Murphy, K McCaffery, KJ McCaffery, L Gething, Linda Sharp, Lisa A McSherry, M Byrne, M Pitts, M Schiffman, Medical Research Council, N Jain, National Cancer Screening Service, National Immunisation Office Ireland, NM Askelson, P Craig, P Naucler, R Anhang, S Franceschi, S Michie, Stephan U Dombrowski, TC Wright, WHO IARC, Z Philips   +53 more
core   +3 more sources

The effects of perceived risk and responsibility on the acceptance of a Human Papillomavirus vaccine by college men [PDF]

, 2009
In the summer of 2006 the Food and Drug Administration approved a new vaccine to prevent four types of the Human Papillomavirus believed to cause the majority of genital warts and cervical cancer in women.
Mitiguy, Angela Marie
core   +1 more source

Applying Multiple Data Collection Tools to Quantify Human Papillomavirus Vaccine Communication on Twitter. [PDF]

, 2016
BACKGROUND: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. There are several vaccines that protect against strains of HPV most associated with cervical and other cancers.
Budenz, Alexandra, Fisher, Kara, Klassen, Ann C., Leader, Amy, Massey, Philip M., Yom-Tov, Elad   +5 more
core   +3 more sources

Human Papillomavirus Vaccine Inaccuracies

American Journal of Public Health, 2012
Although Maine et al. provided a comprehensive overview of the state of cervical cancer prevention today,1 their article presented some inaccuracies and tended to downplay the benefits of vaccination and magnified its challenges. For example, the authors failed to acknowledge that immunization has much less socioeconomic variation than screening does ...
Vivien Davis, Tsu, D Scott, LaMontagne
openaire   +3 more sources

Papillomavirus-Like Particle Vaccines [PDF]

JNCI Monographs, 2000
Papillomavirus-like particle (VLP)-based subunit vaccines have undergone rapid development over the past 8 years. Three types are being investigated. The most basic type is composed of only the L1 major capsid protein and is designed to prevent genital human papillomavirus (HPV) infection by inducing virus-neutralizing antibodies.
J T, Schiller, D R, Lowy
openaire   +2 more sources

Emerging human papillomavirus vaccines [PDF]

Expert Opinion on Emerging Drugs, 2012
Identification of human papillomavirus (HPV) as the etiologic factor of cervical, anogenital, and a subset of head and neck cancers has stimulated the development of preventive and therapeutic HPV vaccines to control HPV-associated malignancies. Excitement has been generated by the commercialization of two preventive L1-based vaccines, which use HPV ...
Barbara, Ma, Bharat, Maraj, Nam Phuong, Tran, Jayne, Knoff, Alexander, Chen, Ronald D, Alvarez, Chien-Fu, Hung, T-C, Wu   +7 more
openaire   +2 more sources